#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	10694	16S	1529	1529	100.0	16S.l15.c30.ctg.1	2143	493.5	1	SNP	n	C1184T	0	.	.	1184	1184	C	1404	1404	C	571	C,G	561,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	10694	16S	1529	1529	100.0	16S.l15.c30.ctg.1	2143	493.5	0	HET	.	.	.	C207T	.	207	207	C	427	427	C	604	C,T	469,119	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	10694	16S	1529	1529	100.0	16S.l15.c30.ctg.1	2143	493.5	0	HET	.	.	.	C451T	.	451	451	C	671	671	C	652	C,T	322,322	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	19954	23S	2890	2890	99.9	23S.l15.c17.ctg.1	3663	542.8	0	.	n	.	0	T695C	SNP	695	695	T	1043	1043	C	665	C,T	642,2	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	19954	23S	2890	2890	99.9	23S.l15.c17.ctg.1	3663	542.8	0	.	n	.	0	A1638G	SNP	1638	1638	A	1986	1986	G	595	G,A	277,311	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	19954	23S	2890	2890	99.9	23S.l15.c17.ctg.1	3663	542.8	0	.	n	.	0	T1971C	SNP	1971	1971	T	2319	2319	C	621	C	604	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	19954	23S	2890	2890	99.9	23S.l15.c17.ctg.1	3663	542.8	1	SNP	n	A2045G	0	.	.	2045	2045	A	2393	2393	A	617	A	608	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	19954	23S	2890	2890	99.9	23S.l15.c17.ctg.1	3663	542.8	1	SNP	n	C2597T	0	.	.	2597	2597	C	2945	2945	C	635	C,T	630,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_Y_01480c	folP.WHO_Y_01480c	1	1	27	1432	folP	855	855	100.0	folP.l15.c4.ctg.1	1472	96.7	1	SNP	p	R229S	1	.	.	685	687	AGC	976	978	AGC	124;126;125	A;G;C	123;125;124	folP.WHO_Y_01480c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	3952	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3516	112.1	1	SNP	p	S91F	1	.	.	271	273	TTC	694	696	TTC	142;141;140	T;T;C	138;136;136	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	3952	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3516	112.1	1	SNP	p	G95N	0	.	.	283	285	GGC	706	708	GGC	136;137;137	G,C;G;C	130,1;134;135	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	3952	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3516	112.1	1	SNP	p	D95G	1	.	.	283	285	GGC	706	708	GGC	136;137;137	G,C;G;C	130,1;134;135	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_V_01454	mtrR.WHO_V_01454	1	1	27	1210	mtrR	633	633	100.0	mtrR.l15.c4.ctg.1	1254	95.8	1	SNP	p	G45D	0	.	.	133	135	GGC	424	426	GGC	149;145;147	G;G,A;C	144;141,1;144	mtrR.WHO_V_01454:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	668	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c4.ctg.1	962	69.3	0	.	n	.	0	A197.	DEL	197	197	A	561	561	A	161	A	154	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	3644	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2960	122.3	1	SNP	p	D86N	0	.	.	256	258	GAC	527	529	GAC	142;141;141	G;A;C	141;135;140	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	3644	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2960	122.3	1	SNP	p	S87R	1	.	.	259	261	CGT	530	532	CGT	142;144;145	C;G;T	141;143;141	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	3644	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2960	122.3	1	SNP	p	R87W	0	.	.	259	261	CGT	530	532	CGT	142;144;145	C;G;T	141;143;141	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	3644	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2960	122.3	1	SNP	p	R87I	0	.	.	259	261	CGT	530	532	CGT	142;144;145	C;G;T	141;143;141	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	3644	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2960	122.3	1	SNP	p	S88P	0	.	.	262	264	TCC	533	535	TCC	146;145;144	T;C;C	144;145;141	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	3002	parE	1986	1986	100.0	parE.l15.c4.ctg.1	2582	115.4	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1537	1539	GGC	135;133;130	G;G;C	132;130;127	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.34.001	penA.34.001	1	1	27	2920	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2406	120.4	1	SNP	p	A311V	0	.	.	931	933	GCC	1257	1259	GCC	165;164;165	G;C;C	161;162;165	penA.34.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	2920	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2406	120.4	1	SNP	p	I312M	1	.	.	934	936	ATG	1260	1262	ATG	167;168;169	A;T;G	164;164;164	penA.34.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	2920	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2406	120.4	1	SNP	p	T316P	0	.	.	946	948	ACC	1272	1274	ACC	168;169;169	A;C;C	163;166;165	penA.34.001:1:1:T316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	2920	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2406	120.4	1	SNP	p	V316T	1	.	.	946	948	ACC	1272	1274	ACC	168;169;169	A;C;C	163;166;165	penA.34.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	2920	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2406	120.4	1	SNP	p	T483S	0	.	.	1447	1449	ACC	1773	1775	ACC	150;151;153	A;C,T;C	143;149,1;151	penA.34.001:1:1:T483S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	2920	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2406	120.4	1	SNP	p	A501P	0	.	.	1501	1503	GCG	1827	1829	GCG	157;159;162	G;C;G	155;155;160	penA.34.001:1:1:A501P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	2920	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2406	120.4	1	SNP	p	A501V	0	.	.	1501	1503	GCG	1827	1829	GCG	157;159;162	G;C;G	155;155;160	penA.34.001:1:1:A501V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	2920	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2406	120.4	1	SNP	p	G542S	0	.	.	1624	1626	GGT	1950	1952	GGT	102;100;100	G;G;T	101;98;96	penA.34.001:1:1:G542S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	2920	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2406	120.4	1	SNP	p	G545S	1	.	.	1633	1635	AGC	1959	1961	AGC	91;92;91	A;G;C	87;89;89	penA.34.001:1:1:G545S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	2920	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2406	120.4	1	SNP	p	P551S	0	.	.	1651	1653	CCG	1977	1979	CCG	84;85;85	C,G;C,A;G	77,1;78,1;68	penA.34.001:1:1:P551S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	4324	ponA	2397	2397	100.0	ponA.l15.c17.ctg.1	3171	135.7	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1725	1727	CCG	145;144;143	C;C;G,C	136;141;135,1	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	1832	porA	1146	1146	99.91	porA.l15.c4.ctg.1	1743	103.9	0	.	p	.	0	M83fs	FSHIFT	247	247	A	517	517	C	141	C,G	134,1	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	204	porB1a	984	271	91.51	porB1a.l15.c30.ctg.2	439	16.1	0	.	p	.	0	A251V	NONSYN	751	753	GCG	65	67	GTA	26;26;26	G;T;A	26;26;26	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	204	porB1a	984	271	91.51	porB1a.l15.c30.ctg.2	439	16.1	0	.	p	.	0	S271T	NONSYN	811	813	TCG	125	127	ACT	34;30;30	A;C;T	34;29;30	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	204	porB1a	984	271	91.51	porB1a.l15.c30.ctg.2	439	16.1	0	.	p	.	0	Y273D	NONSYN	817	819	TAT	131	133	GAT	21;21;21	G;A;T	20;20;20	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	204	porB1a	984	271	91.51	porB1a.l15.c30.ctg.2	439	16.1	0	.	p	.	0	D276N	NONSYN	826	828	GAT	140	142	AAC	22;22;22	A;A;C	21;20;22	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	204	porB1a	984	271	91.51	porB1a.l15.c30.ctg.2	439	16.1	0	.	p	.	0	N277H	NONSYN	829	831	AAC	143	145	CAC	22;22;22	C;A;C	22;22;22	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	204	porB1a	984	271	91.51	porB1a.l15.c30.ctg.2	439	16.1	0	.	p	.	0	R307E	NONSYN	919	921	AGA	233	235	GAA	5;5;5	G;A;A	5;5;5	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	204	porB1a	984	271	91.51	porB1a.l15.c30.ctg.2	439	16.1	0	.	p	.	0	T311A	NONSYN	931	933	ACA	245	247	GCA	7;7;8	G;C;A	7;7;8	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	204	porB1a	984	271	91.51	porB1a.l15.c30.ctg.2	439	16.1	0	.	p	.	0	E312D	NONSYN	934	936	GAA	248	250	GAC	8;8;8	G;A;C	8;8;8	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	204	porB1a	984	271	91.51	porB1a.l15.c30.ctg.2	439	16.1	0	.	p	.	0	F314I	NONSYN	940	942	TTC	254	256	ATC	8;8;8	A;T;C	8;8;8	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	204	porB1a	984	271	91.51	porB1a.l15.c30.ctg.2	439	16.1	0	.	p	.	0	A316S	NONSYN	946	948	GCG	260	262	TCG	9;9;9	T;C;G	8;9;8	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	204	porB1a	984	271	91.51	porB1a.l15.c30.ctg.2	439	16.1	0	.	p	.	0	V318A	NONSYN	952	954	GTC	266	268	GCC	9;10;10	G;C;C	8;10;10	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	204	porB1a	984	271	91.51	porB1a.l15.c30.ctg.2	439	16.1	0	.	p	.	0	G319S	NONSYN	955	957	GGC	269	271	AGC	10;10;10	A;G;C	9;8;10	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	204	porB1a	984	271	91.51	porB1a.l15.c30.ctg.2	439	16.1	0	.	p	.	0	G320A	NONSYN	958	960	GGT	272	274	GCC	10;10;10	G;C;C	8;10;9	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	204	porB1a	984	271	91.51	porB1a.l15.c30.ctg.2	439	16.1	0	.	p	.	0	G322V	NONSYN	964	966	GGT	278	280	GTT	11;11;11	G;T;T	8;11;10	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	27	2172	porB1b	1038	1038	100.0	porB1b.l6.c4.ctg.1	1603	134.6	1	SNP	p	G120K	1	.	.	358	360	AAG	633	635	AAG	178;179;178	A,C;A;G	165,3;173;160	porB1b.WHO_Y_02277c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	27	2172	porB1b	1038	1038	100.0	porB1b.l6.c4.ctg.1	1603	134.6	1	SNP	p	A121N	1	.	.	361	363	AAC	636	638	AAC	181;182;178	A;A;C,A	176;176;164,1	porB1b.WHO_Y_02277c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	27	2172	porB1b	1038	1038	100.0	porB1b.l6.c4.ctg.1	1603	134.6	1	SNP	p	N121D	0	.	.	361	363	AAC	636	638	AAC	181;182;178	A;A;C,A	176;176;164,1	porB1b.WHO_Y_02277c:1:1:N121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	7184	rpoB	4179	4179	99.98	rpoB.l6.c4.ctg.1	4910	145.9	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	890	rpsJ	312	312	100.0	rpsJ.l15.c30.ctg.1	988	89.0	1	SNP	p	V57M	1	.	.	169	171	ATG	518	520	ATG	184;186;185	A;T;G	177;179;179	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
